COMMUNIQUÉS West-GlobeNewswire

-
GUERBET: Résultats annuels 2018
26/03/2019 -
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
26/03/2019 -
OSE Immunotherapeutics Announces New Research Collaboration with Léon Bérard Cancer Center to Use Artificial Intelligence Technologies to Identify Novel Immuno-Oncology Targets
26/03/2019 -
VALNEVA annonce la publication de son Document de Référence 2018
26/03/2019 -
Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina
26/03/2019 -
Nexstim Plc: Nexstim Plc publishes prospectus regarding EUR 5.2 million rights issue and new information regarding previous profit forecast
26/03/2019 -
Orion Corporation: Organising meeting of the Board of Directors
26/03/2019 -
Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestinal Bleeding in LVAD Patients
26/03/2019 -
Orion Corporation: Decisions by the AGM on 26 March 2019
26/03/2019 -
Tauriga Sciences Inc. Expands its Tauri-Gum Product Line with the Establishment of Two Additional Flavors: Blood Orange and Pomegranate
26/03/2019 -
ViroGates announces the launch of suPARnostic® TurbiLatex on all commercially relevant Roche Diagnostics cobas instruments
26/03/2019 -
NFL Hall of Famer, Businessman Roger Staubach to Headline SoldierStrong Fundraiser in Dallas on Thursday
26/03/2019 -
Cognition Therapeutics Elects Lisa Ricciardi to its Board of Directors
26/03/2019 -
Innovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeability and the Gut Microbiota using Larazotide in Immuno-oncology Checkpoint Inhibitor Failure Pre-Clinical Models
26/03/2019 -
Diamond CBD Looks to $72 Billion Pet Industry as Company Puts its MediPets Brand on Showcase at the Global Pet Expo in Orlando
26/03/2019 -
Nexstim Oyj: EUR 5.2 million rights issue Of Nexstim Oyj
26/03/2019 -
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma
26/03/2019 -
Lundbeck held its Annual General Meeting on 26 March 2019 at the company’s registered office
26/03/2019 -
CareDx Files Patent Infringement Lawsuit Against Natera
26/03/2019
Pages